Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brian D Juran

Showing results (21-30 of 60) with videos related to

Pageof 6
Sort By:
Hepatology (Baltimore, Md.)|November 29, 2007
Interacting alleles of the coinhibitory immunoreceptor genes cytotoxic T-lymphocyte antigen 4 and programmed cell-death 1 influence risk and features of primary biliary cirrhosisBrian D Juran, Elizabeth J Atkinson, Erik M Schlicht, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|March 16, 2013
Questionnaire based assessment of risk factors for primary biliary cirrhosisCraig Lammert, Douglas L Nguyen, Brian D Juran, et al.
BMC Gastroenterology|April 2, 2021
Evaluation of circulating cell-free DNA in cholestatic liver disease using liver-specific methylation markersSohan Punia, Brian D Juran, Ahmad H Ali, et al.
Journal of Gastroenterology|December 10, 2013
Biochemical response to ursodeoxycholic acid predicts survival in a North American cohort of primary biliary cirrhosis patientsCraig Lammert, Brian D Juran, Erik Schlicht, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|December 8, 2010
Genetic polymorphisms of matrix metalloproteinase 3 in primary sclerosing cholangitisBrian D Juran, Elizabeth J Atkinson, Erik M Schlicht, et al.
BMC Gastroenterology|September 26, 2021
The PSC scientific community resource: an asset for multi-omics interrogation of primary sclerosing cholangitisAhmad Hassan Ali, Brian D Juran, Erik M Schlicht, et al.
Journal of Gastroenterology and Hepatology|March 1, 2017
Variations in primary sclerosing cholangitis across the age spectrumJohn E Eaton, Bryan M McCauley, Elizabeth J Atkinson, et al.
BMC Gastroenterology|April 19, 2023
Predicting cholangiocarcinoma in primary sclerosing cholangitis: using artificial intelligence, clinical and laboratory dataChang Hu, Ravishankar K Iyer, Brian D Juran, et al.
Hepatology Communications|June 9, 2018
External validation of the United Kingdom-primary biliary cholangitis risk scores of patients with primary biliary cholangitis treated with ursodeoxycholic acidAngela C Cheung, Aliya F Gulamhusein, Brian D Juran, et al.
Hepatology (Baltimore, Md.)|June 26, 2010
Carriage of a tumor necrosis factor polymorphism amplifies the cytotoxic T-lymphocyte antigen 4 attributed risk of primary biliary cirrhosis: evidence for a gene-gene interactionBrian D Juran, Elizabeth J Atkinson, Joseph J Larson, et al.
Pageof 6

Showing results (21-30 of 60) with videos related to

Sort By:
Pageof 6
Hepatology (Baltimore, Md.)|November 29, 2007
Interacting alleles of the coinhibitory immunoreceptor genes cytotoxic T-lymphocyte antigen 4 and programmed cell-death 1 influence risk and features of primary biliary cirrhosisBrian D Juran, Elizabeth J Atkinson, Erik M Schlicht, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|March 16, 2013
Questionnaire based assessment of risk factors for primary biliary cirrhosisCraig Lammert, Douglas L Nguyen, Brian D Juran, et al.
BMC Gastroenterology|April 2, 2021
Evaluation of circulating cell-free DNA in cholestatic liver disease using liver-specific methylation markersSohan Punia, Brian D Juran, Ahmad H Ali, et al.
Journal of Gastroenterology|December 10, 2013
Biochemical response to ursodeoxycholic acid predicts survival in a North American cohort of primary biliary cirrhosis patientsCraig Lammert, Brian D Juran, Erik Schlicht, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|December 8, 2010
Genetic polymorphisms of matrix metalloproteinase 3 in primary sclerosing cholangitisBrian D Juran, Elizabeth J Atkinson, Erik M Schlicht, et al.
BMC Gastroenterology|September 26, 2021
The PSC scientific community resource: an asset for multi-omics interrogation of primary sclerosing cholangitisAhmad Hassan Ali, Brian D Juran, Erik M Schlicht, et al.
Journal of Gastroenterology and Hepatology|March 1, 2017
Variations in primary sclerosing cholangitis across the age spectrumJohn E Eaton, Bryan M McCauley, Elizabeth J Atkinson, et al.
BMC Gastroenterology|April 19, 2023
Predicting cholangiocarcinoma in primary sclerosing cholangitis: using artificial intelligence, clinical and laboratory dataChang Hu, Ravishankar K Iyer, Brian D Juran, et al.
Hepatology Communications|June 9, 2018
External validation of the United Kingdom-primary biliary cholangitis risk scores of patients with primary biliary cholangitis treated with ursodeoxycholic acidAngela C Cheung, Aliya F Gulamhusein, Brian D Juran, et al.
Hepatology (Baltimore, Md.)|June 26, 2010
Carriage of a tumor necrosis factor polymorphism amplifies the cytotoxic T-lymphocyte antigen 4 attributed risk of primary biliary cirrhosis: evidence for a gene-gene interactionBrian D Juran, Elizabeth J Atkinson, Joseph J Larson, et al.
Pageof 6